HIV, Latent HIV-1 infection, HIV therapy, antibody-based therapy
Showing 1 - 25 of >10,000
HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)
Not yet recruiting
- HIV-1-infection
- ART
- +2 more
-
Mbeya, TanzaniaNational Institute for Medical Research-Mbeya Medical Resarch Ce
Jun 6, 2023
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
HIV-1-infection Trial in Chapel Hill (MGD014)
Completed
- HIV-1-infection
- MGD014
-
Chapel Hill, North CarolinaUniversity of North Carolina Chapel Hill
Aug 31, 2022
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Immune Activation and Latent HIV Reservoir Size Between People
Enrolling by invitation
- HIV-1-infection
- +3 more
- Venipuncture
- +4 more
-
Seattle, WashingtonUniversity of Washington Positive Research and the Gastroenterol
Oct 14, 2022
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
HIV Transmission in Era of Scaling up Antiretroviral Therapy in
Recruiting
- HIV-1-infection
- Antiretroviral Therapy
- Exposure to antiretroviral therapy
-
Ādama, Oromia, EthiopiaPublic hospitals and health centers in the Adama uptake area
Dec 15, 2022
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023
Tuberculosis, HIV Coinfection, Tuberculosis Infection Trial (patient-centered TB preventive therapy, TB preventive therapy
Not yet recruiting
- Tuberculosis
- +2 more
- patient-centered TB preventive therapy
- TB preventive therapy adherence support
- (no location specified)
Apr 21, 2022
HIV-1-infection, Metabolic Syndrome Trial (physical activity)
Not yet recruiting
- HIV-1-infection
- Metabolic Syndrome
- physical activity
- (no location specified)
Jun 6, 2023
Targeting of the Latent HIV Infected Reservoir to Cure HIV
Recruiting
- HIV Infections
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Centre
Jan 17, 2022
HIV-1-infection Trial in Aarhus (Venetoclax)
Not yet recruiting
- HIV-1-infection
-
Aarhus, DenmarkAarhus University Hospital
Jan 5, 2023
HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)
Recruiting
- HIV-1-infection
- BCG Vaccine AJVaccines
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 28, 2022
HIV-1-infection Trial in Ghent (Dual versus triple therapy in treatment of HIV-1 infection.)
Recruiting
- HIV-1-infection
- Dual versus triple therapy in treatment of HIV-1 infection.
-
Ghent, BelgiumGhent University Hospital
Dec 5, 2022
HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)
Withdrawn
- HIV Infection
- Analytical Treatment Interruption + bNAbs infusion
-
Milan, Lombardy, Italy
- +3 more
Aug 2, 2022
HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)
Completed
- HIV/AIDS
- Chidamide with CAR-T or TCR-T cell therapy
-
Guangzhou, Guangdong, ChinaGuangzhou 8th People's Hospital
Jul 19, 2021
Post Analytic Treatment Interruption Study
Recruiting
- HIV
-
Bangkok, ThailandSEARCH
Oct 19, 2022
HIV Seropositivity, Pregnancy, Tuberculosis Infection Trial in Tembisa (Rifapentine, Isoniazid)
Not yet recruiting
- HIV Seropositivity
- +2 more
-
Tembisa, Gauteng, South AfricaThe Aurum Institute: Tembisa Clinical Research Centre
Dec 9, 2022
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by invitation
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023